EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H23NO |
| Net Charge | 0 |
| Average Mass | 257.377 |
| Monoisotopic Mass | 257.17796 |
| SMILES | C=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@@H]2C |
| InChI | InChI=1S/C17H23NO/c1-4-8-18-9-7-17(3)12(2)16(18)10-13-5-6-14(19)11-15(13)17/h4-6,11-12,16,19H,1,7-10H2,2-3H3/t12-,16+,17+/m0/s1 |
| InChIKey | LGQCVMYAEFTEFN-JCURWCKSSA-N |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | opioid analgesic A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood. opioid receptor antagonist An agent that binds to but does not activate an opioid receptor thereby blocking the actions of endogenous or exogenous opioid receptor agonists. |
| Applications: | opioid analgesic A narcotic or opioid substance, synthetic or semisynthetic agent producing profound analgesia, drowsiness, and changes in mood. opioid receptor antagonist An agent that binds to but does not activate an opioid receptor thereby blocking the actions of endogenous or exogenous opioid receptor agonists. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (−)-SKF-10,047 (CHEBI:228224) is a SKF-10,047 (CHEBI:228203) |
| IUPAC Name |
|---|
| (2R,6R,11R)-6,11-dimethyl-3-(prop-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol |
| Synonyms | Source |
|---|---|
| (2R,6R,11R)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propen-1-yl)-2,6-methano-3-benzazocin-8-ol | ChEBI |
| (−)-alazocine | ChEBI |
| l-N-allylnormetazocine | ChEBI |
| l-SKF 10047 | ChEBI |
| (−)-N-allylnormetazocine | ChEBI |
| (−)-NANM | ChEBI |
| Registry Numbers | Sources |
|---|---|
| CAS:14198-28-8 | ChEBI |
| Citations |
|---|